Ron Pearson is NOT on the board.... just more lies (This

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco
Ron Pearson is NOT on the board.... just more lies

(This was deleted in record time on ILIE by we all know who....)

Quote:
Posted by: CyberBULLSHITmouse on ILIE

I personally know Ron Pearson who ran Hy-Vee through much of their astronomical growth and is still on the board. This comical penny bullshit is purely for laughs.



http://producenews.com/news-dep-menu/test-fea...-directors

2016 Hy-Vee Board of Directors

Randy Edeker, chairman, CEO and president
Andy McCann, vice chairman, executive vice president, chief administrative officer
Mike Skokan, executive vice president, chief financial officer, treasurer
Jon Wendel, executive vice president, chief merchandising officer
Jay Marshall, executive vice president, chief operating officer
Sheila Laing, executive vice president, chief customer officer
Brett Bremser, executive vice president of Hy-Vee’s western region
Darren Baty, executive vice president of Hy-Vee’s eastern region
Mic Jurgens, senior vice president, secretary, general counsel
Kristin Williams, senior vice president, pharmacy operations
Jamie Franck, district vice president of Hy-Vee’s eastern district
Martin Stokes, store director at the Peony Park Hy-Vee in Omaha, Nebraska
Matt Schweizer, store director at the Muscatine Mainstreet Hy-Vee in Muscatine, Iowa
Kevin Mills, store director at the Lincoln Center Hy-Vee in Ames, Iowa
Jennifer Knesel, store director at the Winona Hy-Vee in Winona, Minnesota
Todd Wagner, store director at the Blue Springs Hy-Vee in Blue Springs, Missouri
Dan Vondrak, store director at the Hilltop Hy-Vee in Mankato, Minnesota

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading